Prorenin and microvascular complications in NIDDM and IDDM.

被引：0
|
作者：
Davies, L
Fulcher, G
CliftonBligh, P
McElduff, A
Monaghan, J
Robinson, B
Stiel, G
Stokes, G
Twigg, S
Wilmshurst, E
机构：
来源：
DIABETES | 1996年 / 45卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：777 / 777
页数：1
相关论文
共 50 条
  • [21] Family clustering of elevated plasma LP(a) in IDDM.
    Ghelardi, R
    Zerbini, G
    Ciralli, F
    Bognetti, E
    Pastore, MR
    DelGiudice, R
    Meregalli, G
    Tettamanti, C
    Ruotolo, G
    Mangili, R
    Pozza, G
    DIABETOLOGIA, 1997, 40 : 1642 - 1642
  • [22] Alanine and terbutaline in the prevention of nocturnal hypoglycemia in IDDM.
    Saleh, T
    Cryer, PE
    DIABETES, 1996, 45 : 201 - 201
  • [23] Large kidneys as marker for subsequent nephropathy in IDDM.
    Baumgartl, HJ
    Banholzer, P
    Haslbeck, M
    Standl, E
    DIABETOLOGIA, 1997, 40 : 2101 - 2101
  • [24] Impact of exercise on cardiovascular risk factors in IDDM.
    Lehmann, R
    Kaplan, V
    Bingisser, R
    Bloch, K
    Spinas, GA
    DIABETES, 1997, 46 : 219 - 219
  • [25] Family planning behavior in young women with IDDM.
    CharronProchownik, D
    Wilson, S
    Maihle, T
    Delullo, N
    Kennedy, B
    Rohay, J
    DIABETES, 1996, 45 : 651 - 651
  • [26] Using Humalog in IDDM. Good idea or bad mistake?
    OKeeffe, B
    Miles, P
    Cavan, D
    Kerr, D
    DIABETES, 1997, 46 : 373 - 373
  • [27] Hypoglycaemia-incidence and clinical predictors in children with IDDM.
    Davis, EA
    Keating, B
    Byrne, GC
    Jones, TW
    DIABETES, 1996, 45 : 213 - 213
  • [28] Progression from microalbuminuria to diabetic nephropathy in IDDM.
    Rossing, P
    Hougaard, P
    BorchJohnsen, K
    Parving, HH
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1997, 8 : A0558 - A0558
  • [29] Prevention of nocturnal hypoglycemia in intensive therapy of IDDM.
    Fanelli, C
    Pampanelli, S
    Lepore, M
    Porcellati, F
    Bartocci, L
    Brunetti, P
    Bolli, GB
    DIABETOLOGIA, 1998, 41 : A69 - A69
  • [30] Polymorphism of complement C4 and susceptibility to IDDM and microvascular complications
    Lhotta, K
    Auinger, H
    Kronenberg, F
    Irsigler, K
    Konig, P
    DIABETES CARE, 1996, 19 (01) : 53 - 55
12345